Physician profile
Ernest Daniel Mackey
NPI 1326017690
$778.32
in general payments reported to CMS, 2019-2025
10 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $16.83 · 2021: $13.87 · 2022: $151 · 2023: $109 · 2024: $176 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $251.91 | 2019-2025 | Gardasil 9, Vaqta, Vaxelis |
| Pfizer INC. | $108.40 | 2019-2025 | |
| Ars Pharmaceuticals Operations, INC. | $95.80 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $85.02 | 2019-2025 | Bexsero, Penmenvy |
| Sanofi-Aventis U.S. LLC | $55.18 | 2024 | |
| Kaleo, INC. | $54.72 | 2019-2023 | Auvi-Q |
| Seqirus USA INC | $46.39 | 2022 | |
| Alk-Abello, INC | $45.30 | 2025 | Neffy |
| Phadia US INC. | $18.77 | 2022 | |
| Vyne Pharmaceuticals INC. | $16.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.